Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway

European Journal of Endocrinology

Volumn 151, Issue 2, 2004, Pages 233-240

  Nanzer, Alexandra M ^a   Khalaf, Sahira ^a   Mozid, Abdul M ^a   Fowkes, Robert C ^a   Patel, Mayur V ^a   Burrin, Jacky M ^a   Grossman, Ashley B ^a   Korbonits, Márta ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; HORMONE PRECURSOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; TRITIUM; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HYPOPHYSIS TUMOR; IMMUNOBLOTTING; ISOTOPE LABELING; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC CELL; TUMOR CELL LINE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BUTADIENES; CARCINOGENS; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; INDOLES; MALEIMIDES; MAP KINASE SIGNALING SYSTEM; NITRILES; PEPTIDE HORMONES; PHOSPHORYLATION; PITUITARY GLAND; PITUITARY NEOPLASMS; RATS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TYRPHOSTINS;

EID: 2942597289     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510233     Document Type: Article

References (40)

1. Korbonits M, Goldstone AP, Gueorguiev M & Grossman AB. Ghrelin - a hormone with multiple functions. Front Neuroendocrinology 2004 25 27-68.
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660.
3. Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nature Review Neuroscience 2001 2 551-560.
4. Hosoda H, Kojima M, Matsuo H & Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. Journal of Biological Chemistry 2000 275 21995-22000.
5. Hosoda H, Kojima M, Mizushima T, Shimizu S & Kangawa K. Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing. Journal of Biological Chemistry 2003 278 64-70.
6. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB & Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. Journal of Clinical Endocrinology and Metabolism 2002 87 2988-2991.
7. Cassoni P, Papotti M, Catapano F, Ghe C, Deghenghi R, Ghigo E & Muccioli G. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. Journal of Endocrinology 2000 165 139-146.
8. Volante M, AllIa E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G & Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines: expression and effects on tumor growth. American Journal of Pathology 2003 162 645-654.
9. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E & Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. Journal of Clinical Endocrinology and Metabolism 2001 86 1738-1745.
10. Ghe C, Cassoni P, Catapano F, Marrocco T, Deghenghi R, Ghigo E, Muccioli G & Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 2002 143 484-491.
11. Jeffery PL, Herington AC & Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. Journal of Endocrinology 2002 172 R7-R11.
12. Jeffery PL, Herington AC & Chopin LK. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Reviews 2003 14 113-122.
13. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K & Chihara K. Ghrelin modulates the downstream of insulin signaling in hepatoma cells. Journal of Biological Chemistry 2002 277 5667-5674.
14. Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP & Nussdorfer GG. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Letters 2003 536 173-179.
15. Choi K, Roh SG, Hong YH, Shrestha YB, Hishikawa D, Chen C, Kojima M, Kangawa K & Sasaki S. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 2003 144 754-759.
16. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E & Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. Journal of Cell Biology 2002 159 1029-1037.
17. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K & Grossman AB. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 2001 86 881-887.
18. Korbonits M, Chitnis MM, Gueorguiev M, Norman D, Rosenfelder N, Suliman M, Jones TH, Noonan K, Fabbri A, Besser GM, Burrin JM & Grossman AB. The release of leptin and its effect on hormone release from human pituitary adenomas. Clinical Endocrinology 2001 54 781-789.
19. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA & Trzaskos JM. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. Journal of Biological Chemistry 1998 273 18623-18632.
20. Wang H, Ubl JJ, Stricker R & Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. American Journal of Physiology Cell Physiology 2002 283 C1351-C1364.
21. Okada T, Sakuma L, Fukui Y, Hazeki O & Ui M. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidyl-inositol 3-kinase. Journal of Biological Chemistry 1994 269 3563-3567.
22. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioko T & Hidaka H. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. Journal of Biological Chemistry 1990 265 5267-5272.
23. Kim K, Arai K, Sanno N, Osamura RY, Teramoto A & Shibasaki T. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clinical Endocrinology 2001 54 759-768.
24. Korbonits M, Jacobs RA, Aylwin SJB, Burrin JM, Dahia PLM, Monson JP, Trainer PJ, Chew SL, Besser GM & Grossman AB. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 3624-3630.
25. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K & Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 2001 22 153-183.
26. van Biesen T, Luttrell LM, Hawes BE & Lefkowitz RJ. Mitogenic signaling via G protein-coupled receptors. Endocrine Reviews 1996 17 698-714.
27. Fowkes RC, Burch J & Burrin JM. Stimulation of extracellular signal-regulated kinase by pituitary adenylate cyclase-activating polypeptide in alpha T3-1 gonadotrophs. Journal of Endocrinology 2001 171 R5-R10.
28. Naor Z, Benard O & Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends in Endocrinology and Metabolism 2000 11 91-99.
29. Smith J, Yu R & Hinkle PM. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis. Molecular Endocrinology 2001 15 1539-1548.
30. Lania A, Filopanti M, Corbetta S, Losa M, Ballare E, Beck-Peccoz P & Spada A. Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells. Journal of Clinical Endocrinology and Metabolism 2003 88 1692-1696.
31. Luttrell LM, Daaka Y & Lefkowitz RJ. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Current Opinion in Cell Biology 1999 11 177-183.
32. Marinissen MJ & Gutkind JS. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends in Pharmacological Sciences 2001 22 368-376.
33. Howard AD, Feighner SD, Cully DF, Liberator PA, Arena JP, Rosenblum CI, Hamelin MJ, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu K, Kulja McKee K, Pong S-S, Chuang LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG & Van der Ploeg LHT. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996 273 974-977.
34. Kranenburg O & Moolenaar WH. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists. Oncogene 2001 20 1540-1546.
35. Shah BH, Soh JW & Catt KJ. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation. Journal of Biological Chemistry 2003 278 2866-2875.
36. Schiemann WP & Nathanson NM. Involvement of protein kinase C during activation of the mitogen-activated protein kinase cascade by leukemia inhibitory factor. Evidence for participation of multiple signaling pathways. Journal of Biological Chemistry 1994 269 6376-6382.
37. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, Xu S & Cobb MH. New insights into the control of MAP kinase pathways. Experimental Cell Research 1999 253 255-270.
38. Orkin RD, New DI, Norman D, Chew SL, Clark AJL, Grossman AB & Korbonits M. Rapid desensitisation of the growth hormone secretagogue (ghrelin) receptor to hexarelin in vitro. Journal of Endocrinological Investigation 2003 26 743-747.
39. Adams EF, Huang B, Buchfelder M, Howard AD, Smith RG, Feighner SD, Van der Ploeg LHT, Bowyers CY & Fahlbusch R. Presence of growth hormone secretagogue receptor messenger ribonucleic acid in human pituitary tumors and rat GH3 cells. Journal of Clinical Endocrinology and Metabolism 1998 83 638-642.
40. Bercu BB, Yang SW Masuda R & Walker RF. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone. Endocrinology 1992 130 2579-2586.